For further details see:
Immatics begins dosing of IMA203 with Bristol Myers' Opdivo in trial to treat solid tumorsFor further details see:
Immatics begins dosing of IMA203 with Bristol Myers' Opdivo in trial to treat solid tumorsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
Bristol-Myers Squibb Company Website:
2024-07-25 10:45:04 ET Avantor Inc. (AVTR) AVTR is trading UP for the last 5 days, and it at trading at $22.39 with volume of 6,161,926 and a one day change of $0.02 (0.07%). Avantor Inc. has a 52-week low of 16.63 and a 52-week high of $26.16. The business's 50-day moving average p...
NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Bristol Myers Squibb Company Our Approach to ESG At BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development a...
The Application is based on Phase 3 CheckMate - 9DW trial results demonstrating improved survival with Opdivo plus Yervoy compared to investigator’s choice of lenvatinib or sorafenib in this patient population Bristol Myers Squibb (NYSE: ...